Le Lézard
Classified in: Health
Subjects: CCA, FVT

Edwards Lifesciences To Host Earnings Conference Call on January 31, 2019


IRVINE, Calif., Jan. 17, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2018 after the market closes on Thursday, January 31, 2019, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

Edwards Lifesciences logo. (PRNewsFoto/Edwards Lifesciences Corporation)

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893.  For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using conference number 13686196.  The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at ir.edwards.com. A live stream and archived replay can also be accessed via mobile devices by downloading Edwards' IR App for iPhone and iPad or Android

About Edwards Lifesciences
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.  Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit www.Edwards.com and follow us on Twitter @EdwardsLifesci.

Edwards is a trademark of Edwards Lifesciences Corporation.  Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

 

SOURCE Edwards Lifesciences Corporation


These press releases may also interest you

at 09:41
SPARK Neuro, a leader in brain health diagnostics, announces the appointment of Dr. Richard J. Caselli as its Medical Director. With a 35-year career at the Mayo Clinic, Dr. Caselli brings extensive expertise and leadership in neurology and cognitive...

at 09:30
LiveOnNY, the federally designated organ procurement organization (OPO) for the NY Metro region announce strategic collaboration with the National Association of Health Services Executives New York Regional Chapter (NAHSE NYR) to increase organ, eye...

at 09:30
Originally founded in Texas, leading massage and wellness franchise, Massage Heights, inks a multi-unit agreement to continue expanding in their home state. The two new locations will provide an elevated experience to those in the Dallas-Fort Worth...

at 09:30
Annovianttm, Inc., a pioneering company with a breakthrough TxGuardtm technology platform for soft-tissue healing, currently focused on cardiovascular field, proudly announces receipt of a $2.99 million grant (SBIR Phase 2b) from the National...

at 09:27
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer,...

at 09:27
BioArctic AB (publ) hereby announces that the Nomination Committee for BioArctic AB (publ) presents the following proposals regarding the resolution on the number of board members and the election of board members and Chairperson of the Board at the...



News published on and distributed by: